Sanofi Targets Accord Over Generic Taxotere
Sanofi-Aventis US LLC has launched a suit seeking to stop Accord Healthcare Inc. USA from taking steps to market a generic copycat of cancer treatment Taxotere....To view the full article, register now.
Already a subscriber? Click here to view full article